Merz Pharma
|
Merz Pharma GmbH & Co. KGaA
|
|
|---|---|
 |
|
| legal form | GmbH & Co. KGaA |
| founding | 1908 |
| Seat | Frankfurt am Main |
| management | Philip Burchard, managing director
Andreas R. Krebs , chairman of the supervisory board |
| Number of employees | 3151 |
| sales | 1.024 billion euros (2017/18) |
| Branch | Pharmaceutical industry |
| Website | www.merz.de |
| As of October 31, 2018 | |
The Merz Pharma GmbH & Co. KGaA is an international aesthetic and pharmaceutical company headquartered in Frankfurt am Main , German production sites in Reinheim and Dessau and other international locations. The company develops and produces, among other things, products and medical technology devices for aesthetic medicine, medicines for patients with neurological movement disorders, and other prescription medicines.
The Merz Pharma company
Merz Pharma controls the activities of its subsidiaries Merz Pharmaceuticals GmbH and Merz Consumer Care GmbH.
Merz Pharmaceuticals
Merz Pharmaceuticals focuses on the two business areas Aesthetics and Specialty Neurology. In the field of aesthetics, Merz offers products that help improve the appearance by tightening and rejuvenating the skin, as well as medical technology devices for non-invasive treatments.
In the field of special neurology, Merz researches and develops therapy solutions for patients who suffer from neurologically caused movement disorders such as dystonia and spasticity .
In 2013, Merz bought the Swiss company Neocutis, which primarily sells aesthetic dermatology products through doctors in the USA, and in the same year took over the Swiss company Anteis, which produces fillers for aesthetic medicine. With the acquisition of the US company Ulthera for almost 600 million US dollars in 2014, Merz entered the business with medical devices for non-invasive facelifts . In the USA, Ulthera sells, among other things, a device that has been approved by the American drug approval authorities and which doctors can use to effectively treat cellulite .
Merz Consumer Care
Merz Consumer Care GmbH develops health, beauty and wellness products that are sold under the brand names Merz Spezial (e.g. Merz Spezial Dragees ) and tetesept.
The products for self-medication include remedies for colds as well as preparations for the prevention of illnesses, for the treatment of everyday ailments and disorders. Merz Consumer Care also produces bath products, vitamins, minerals and preparations for skin, hair and fingernails.
history
The company, founded by Friedrich Merz in 1908, is in the fourth generation, privately owned by the Baatz, Hückmann, Meyer and Nick families and celebrated its 100th anniversary in 2008. The following table shows the most important milestones:
1908 - Merz founded
1911 - Introduction of Patentex
1953 - Introduction of Placentubex ®
1964 - Development and introduction of the Merz Spezial ® coated tablets
1965 - Introduction of tetesept ®
1968 - Development of the Placentubex ® foam mask
2002 - Introduction of Memantine
2005 - Development of a new generation of botulinum toxin
2010 - Takeover of the company Bioform with the product RADIESSE ®
2013 - Takeover of the Anteis company with the Belotero ® product range
2013 - Acquisition of the Swiss skin care company Neocutis
2014 - Takeover of the Ulthera ® system
2015 - Launch of Radiesse ® (+) Lidocaine in the USA
2015 - Foundation of the Asia Pacific location in Singapore
2016 - Takeover of ON Light Sciences with the DeScribe ® product
2016 - Introduction of the Cellfina ® system in the USA
2018 - Development of Belotero ® Lips
2019 - Development of Belotero ® Revive
Individual evidence
- ↑ a b Business figures of the Merz Pharma Group - Merz Pharma Germany. In: merz.com. Retrieved November 1, 2018 .
- ↑ Merz is attracted by the beauty business. Retrieved October 8, 2014 .
- ↑ Ulthera's CEO explains Merz Pharma Group $ 600M deal. Retrieved June 26, 2014 .
- ↑ New Cellulite Treatment, Cellfina, Gets Approved By The FDA: Will It Actually Work? Retrieved August 22, 2015 .
- ↑ tetesept.de .
- ↑ Merz Pharma Group Acquires Swiss Dermatology Company Neocutis SA ( en ) July 31, 2013.
- ↑ Merz Aesthetics Launches New Belotero® Lips Dermal Filler Products ( en ) April 9, 2018.
- ↑ Merz Launches New Belotero® Revive Dermal Filler ( en ) April 5, 2019.